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A B S T R A C T
Tissue engineering is a branch of regenerative medicine that aims to manipulate cells and scaffolds to create
bioartificial tissues and organs for patients. A major challenge lies in monitoring the blood supply to the new
tissue following transplantation: the integration and neovascularization of scaffolds in vivo is critical to their
functionality. Photoacoustic imaging (PAI) is a laser-generated ultrasound-based technique that is particularly
well suited to visualising microvasculature due to the high optical absorption of haemoglobin. Here, we describe
an early proof-of-concept study in which PAI in widefield tomography mode is used to image biological, de-
cellularized human tracheal scaffolds. We found that PAI allowed the longitudinal tracking of scaffold in-
tegration into subcutaneous murine tissue with high spatial resolution at depth over an extended period of time.
The results of the study were consistent with post-imaging histological analyses, demonstrating that PAI can be
used to non-invasively monitor the extent of vascularization in biological tissue-engineered scaffolds. We pro-
pose that this technique may be a valuable tool for studies designed to test interventions aimed at improving the
speed and extent of scaffold neovascularization in tissue engineering. With technological refinement, it could
also permit in vivo monitoring of revascularization in patients, for example to determine timing of heterotopic
graft transfer.
1. Introduction
The field of tissue engineering aims to regenerate tissues or whole
organs for clinical transplantation and fuses aspects of materials sci-
ence, biomedical engineering and cell biology. An important lesson
from early clinical translation of tissue-engineered products in various
settings has been the importance of scaffold integration for long-term
graft survival. Several processes are involved in the integration of the
scaffold with recipient tissue, but one important aspect is the estab-
lishment of a vascular network within the graft as the requirement for
nutrients and oxygen often cannot be met by simple diffusion. The
ability to monitor angiogenesis, the process of new blood vessel for-
mation from pre-existing vasculature [1,2], in implanted scaffolds in
real-time in vivo would facilitate comparisons of vascularization in
different scaffold materials and assist in the development of therapeutic
strategies that promote vascularization [3,4]. However, monitoring
vascularization in bioengineered scaffolds is currently challenging [5].
As such, the development of new methods to investigate angiogenesis in
tissue-engineered scaffolds could lead to improved therapeutic out-
comes for patients who require bioengineered tissues and organs [6].
The techniques currently used for preclinical in vivo monitoring of
angiogenesis include magnetic resonance imaging (MRI), ultrasound
(US), micro-computed tomography (microCT), positron emission to-
mography (PET), single-photon emission computed tomography
(SPECT), optical microscopy and optical coherence tomography (OCT)
[7–10]. The limitations of these techniques include the need for exo-
genous contrast agents or radiotracers for visualizing small vessels in
MRI, PET, SPECT and ultrasound and the use of ionizing radiation in
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microCT [7,9]. Optical imaging techniques such as confocal, multi-
photon microscopy or OCT can provide high resolution images of the
microvasculature without the need for ionizing radiation [11–13] but
the penetration depth that can be obtained is limited to approximately
1mm due to the strong optical scattering exhibited by tissue [14].
Photoacoustic imaging (PAI) is an emerging hybrid imaging modality
that offers the prospect of overcoming these limitations [15–17]. It is
based upon the generation of broadband ultrasound waves by the ab-
sorption of low energy laser pulses by tissue chromophores. These
waves are then detected at the tissue surface and used to reconstruct a
3D image of the internal tissue structure. This approach offers several
advantages. Since acoustic waves are scattered much less than photons
in tissue, it avoids the penetration depth limitations of the purely op-
tical imaging techniques mentioned above. In addition, contrast is de-
fined primarily by optical absorption. This makes PAI particularly well
suited to visualizing the microvasculature without the need for exo-
genous contrast agents due to the strong optical absorption of he-
moglobin [18]. Several preclinical studies have exploited the high mi-
crovascular contrast provided by PAI to non-invasively visualize
angiogenesis in simple, synthetic, non-biological poly(lactic-co-glycolic
acid) (PLGA) scaffolds implanted subcutaneously in the rodent ear or
flank [19,20]. However, the utility of PAI for determining the
integration and vascularization of human biological scaffolds has not
yet been investigated. Biological scaffolds have greater potential to be
clinically translated as bioartificial tissues and organs than synthetic
scaffolds because of their near-native tissue architecture and bio-
compatibility in the recipient [21].
In the current work, a proof-of-concept study was undertaken in
which the integration and neovascularization of a complex composite
biological tissue scaffold – decellularized human trachea – was mon-
itored longitudinally over a 15-week period. This decellularized tissue,
consisting of layers of cartilage, fibrous intercartilaginous zones, muscle
and mucosa, was implanted subcutaneously into murine flank and PAI
in tomography mode was used to visualize neovascularization. This
enabled the scaffold to be visualized at greater depths than optical
microscopy techniques, including optical resolution photoacoustic mi-
croscopy (OR-PAM), where the imaging depth is limited to approxi-
mately 1mm by tissue optical scattering [22].
2. Materials and methods
2.1. Scaffold preparation
Human tracheae were obtained from cadaveric donors aged
Fig. 1. Photoacoustic imaging to monitor neovascu-
larization in biological tissue-engineered scaffolds. (a)
A dorsal incision was created on the flank of a mouse
and a scaffold, containing fiducial sutures, was im-
planted subcutaneously within a pocket fashioned on
the flank, away from the incision line. (b)
Experimental timelines showing the scaffold im-
plantation, photoacoustic (PA) imaging time points
and retrieval of the implanted scaffold. (c) A schematic
showing the PA tomographic imaging setup. A large
diameter pulsed laser beam illuminates the tissue vo-
lume containing the implanted scaffold, generating
photoacoustic waves. The photoacoustic waves are
detected by the all-optical Fabry-Perot (FP) ultrasound
sensor head. The FP sensor is read-out by optically
scanning a focused sensor interrogation laser beam
across its surface, recording the photoacoustic signals
at each scan point.
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between 30–80 years by the National Health Service Blood and
Transplant (NHSBT) tissue retrieval team. Ethical approval was granted
by the National Research Ethics Committee (REC reference 11/LO/
1522). Tracheae were retrieved within the first 48 h post-mortem and
removed in their entirety from cricoid to carina. After retrieval, donor
tracheae were rinsed in 1 L 0.9% normal saline and surrounding tissue
was dissected away. The tracheae were immersed in 20% chlorhexidine
solution for 5min followed by a further three washes in 0.9% saline.
Intact tracheae were processed using the detergent-enzymatic de-
cellularization method (DEM) as described by Conconi et al. [23].
Briefly, tracheae were subjected to 25 cycles of distilled water for 72 h
at 4 °C, 4% sodium deoxycholate (Sigma) for 4 h and 2000 kU DNase-I
in 1M sodium chloride (Sigma) for 3 h. They were continuously rotated
on a roller throughout the decellularization process. These were fash-
ioned into 0.5–1.0 cm width, full-thickness tissue graft and fiducial
sutures (5/0 Prolene) were inserted into the scaffold. After decellular-
ization, scaffolds were gamma irradiated (10,000 Gy) and were stored
at 4 °C in PBS until use. One scaffold was injected with 33 ng VEGF
(Sigma) in 100 μl PBS at the time of implantation.
2.2. Subcutaneous implantation model
All animal studies were approved by the University College London
Biological Services Ethical Review Committee and licensed under the
UK Home Office regulations and the Guidance for the Operation of
Animals (Scientific Procedures) Act 1986 (Home Office, London, United
Kingdom). Adult CD1 mice (n=6) were used for subcutaneous im-
plantation of scaffolds. Mice were anaesthetized with a 2–5% iso-
florane:oxygen gas mix for induction and maintenance. Under aseptic
conditions, the dorsum of each mouse was shaved and chlorhexidine
solution applied. A 5mm transverse dorsal incision was made to raise a
subcutaneous pocket for implantation of the scaffold (Fig. 1a). This was
done so that the scaffold was implanted away from the surgical incision
site, ensuring that there is as little influence as possible from angio-
genesis resulting from superficial skin wound healing. A single prepared
tracheal scaffold, 7mm in diameter, with an accompanying nylon
marking suture fashioned as a cross, was inserted into the pocket. The
suture is optically absorbing and thus provides photoacoustic contrast
enabling it to be used as an identification marker during the imaging
process. The pocket was closed with buried 4/0 Vicryl interrupted su-
tures. The scaffolds implanted in (n= 3) mice were imaged long-
itudinally at five set time points, as described in Section 2.3, for a total
of 15 weeks. After 15 weeks, the scaffolds were retrieved en bloc for
histological analyses. A timeline of the study is shown is shown in
Fig. 1b.
2.3. Photoacoustic Imaging (PAI)
Photoacoustic signals were generated and detected using an all-
optical preclinical photoacoustic scanner which operates in tomography
mode. This mode of PAI uses a wide-field excitation beam to irradiate a
relatively large volume of tissue [15]. It provides greater penetration
depth (mm-cm) than the sub-mm depths provided by optical resolution
photoacoustic microscopy (OR-PAM) [22] previously used to char-
acterize synthetic scaffolds [19]. A detailed description of the design
and operation of the scanner, which is based on a Fabry-Perot (FP)
polymer film ultrasound sensor, has been reported previously [24,25],
but a brief description is given here, following the schematic given in
Fig. 1c.
The scanner employs a tunable optical parametric oscillator (OPO)
based laser system (Quanta Ray Pro-270/premiScan, Newport Spectra
Physics/GWU Lasertechnik) as the excitation source. This system pro-
vides 7 ns laser pulses at a pulse repetition frequency of 50 Hz and can
be tuned over the range 410 nm–2100 nm. The output of the laser is
coupled into a multimode optical fibre. The distal end of the fibre was
positioned so as to irradiate the skin surface with a 2 cm diameter beam
which is transmitted through the FP sensor; the latter is possible be-
cause the sensor is designed to be transparent to wavelengths between
590 nm and 1200 nm. The absorption of the excitation light by the
tissue generates photoacoustic waves which are detected by the sensor
on to which the mouse was placed. The sensor itself is a thin film
structure comprising two dichroic mirrors, separated by a 40 μm thick
polymer film spacer, thus forming a Fabry Perot interferometer.
Photoacoustic waves incident on the sensor modulate the optical
thickness of the polymer spacer. This produces a corresponding mod-
ulation in the sensor reflectivity which is detected using a focused in-
terrogation laser beam at ˜1550 nm (where the sensor mirrors are
highly reflective) that is incident on the sensor. In order to map the
spatial distribution of the incident photoacoustic waves, the inter-
rogation laser beam is scanned point-by-point over the surface of the
sensor. The sensor has a uniform broadband frequency response with a
-3 dB bandwidth of 22MHz and the optically defined element diameter
was 60 μm. The scanner provides a maximum lateral field of view of
20× 20mm, a depth-dependent spatial resolution in the range
50–150 μm and a penetration depth of approximately 10mm depending
on excitation wavelength [24,25].
Before imaging, mice were anaesthetized using isoflurane in oxygen
[4% (vol/vol) at a flow rate of 2 L/min for induction and 1.5% (vol/vol)
at a flow rate of 1 L/min for maintenance]. A regulated heating system
maintained the ambient temperature around the anaesthetized mice at
34 °C. In order to achieve acoustic coupling between the sensor and the
mice, a small amount of ultrasound gel was applied to the surface of the
mouse skin. In this study, the scan area was 14mm x 14mm with a step
size of 100 μm. For each scan, approximately 20,000 waveforms were
therefore acquired, each containing 640 time points and each scan took
approximately 7min to complete, limited by the repetition rate of the
excitation laser. The maximum laser pulse energy used in this study was
18mJ. The beam diameter incident on the mouse skin was 2 cm, thus
the incident fluence was below 6mJ/cm [2].
Three-dimensional photoacoustic images were reconstructed from
the acquired photoacoustic signals, using a time reversal algorithm [26]
with a correction for tissue acoustic attenuation implemented using a
time variant filtering method [27]. The image reconstruction algorithm
was implemented using k-Wave, an open source MATLAB toolbox de-
veloped at University College London for the time-domain simulation
and reconstruction of photoacoustic and ultrasound wave fields (www.
k-wave.org) [28]. The sound speed used in the reconstruction was se-
lected using an autofocus approach, based on a metric of image
sharpness [29]. The reconstructed images were displayed as maximum
intensity projections (MIPs) using a logarithmic image intensity scale.
Volume rendering of the reconstructed 3D dataset was using Amira
software (FEI Visualization Sciences).
2.4. Histological analysis
Retrieved samples were fixed in 4% paraformaldehyde (PFA)
overnight at 4 °C prior to processing for paraffin embedding.
Hematoxylin and eosin (H&E) staining was performed on 5 μm thick-
ness paraffin sections using an automated staining system (Tissue-Tek).
For immunohistochemistry, paraffin sections were dewaxed using an
automated protocol and antigen retrieval was performed using citrate
buffer (pH 6.0). Vasculature was identified using an antibody against
endomucin (Abcam; ab106100). Species-appropriate secondary anti-
bodies were used (AlexaFluor dyes; Molecular Probes).
3. Results
3.1. Study overview
Donor human tracheae were decellularized before subcutaneous
implantation into the dorsal flank of mice (Fig. 1a). The incisions
healed without complications in 5–7 days and there were no wound or
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implant complications during the 15 weeks of the study. The integra-
tion of the tissue-engineered scaffold was monitored by acquiring
photoacoustic images at five time points over the course of 15 weeks
(Fig. 1b). At the end of the study, the decellularized scaffolds appeared
well-integrated with host tissue macroscopically (Fig. 2b). Larger ma-
ture vessels overlying the scaffold were visible. All mice tolerated the
study well and recovered uneventfully from anesthesia during repeated
imaging.
3.2. Optimization of photoacoustic imaging for visualization of tissue-
engineered scaffolds
To identify the optimum imaging parameters and provide an initial
assessment of the ability of the scanner to visualize neovascularization
Fig. 2. Integration of a decellularized human tracheal scaffold visualized by photoacoustic imaging. (a) Photograph of a representative acellular scaffold before
implantation. (b) Photograph of a representative scaffold retrieved after 15 weeks in vivo. The clear translucent scaffold before implantation became integrated with
the existing murine skin vasculature, indicated with green and yellow arrows. In vivo photoacoustic (PA) images of the same scaffold were acquired at 600 nm and
850 nm before retrieval at 15 weeks and are shown as horizontal and vertical maximum intensity projections (MIPs) (c–f). Horizontal x–y MIPs at (c) 600 nm and (d)
850 nm excitation wavelengths, respectively. The yellow dotted ellipses show the region where neo-angiogenesis occurs around the scaffold. The depth of the vessels
imaged can be referenced to the color scale on right of the image, with red being most superficial and green to turquois showing vessels deeper within the tissue. The
cross shaped sutures inserted into the scaffold to act as fiducial markers can be seen (indicated by blue arrows throughout). Vertical x–z MIPs acquired at (e) 600 nm
and (f) 850 nm excitation wavelengths, respectively. The improved imaging depth at 850 nm, compared to 600 nm, is shown by the visibility of deeper lying vessels
(yellow and green arrows) that are not visible at 600 nm (e vs f). An animated volume rendered representation of the data acquired at 850 nm is available online. In
the volume rendered animation, the suture markers within the scaffolds have been false coloured blue, to aid identification of the scaffold. The scaffold itself does not
provide PA contrast, and thus appears as a void. The vasculature that is false colored red is located on the underside of the scaffold and is connected to the skin
vasculature. (MP4 video, 1.1MB).
O. Ogunlade et al. Photoacoustics 13 (2019) 76–84
79
around the implanted scaffolds, a set of in vivo photoacoustic images
was initially acquired at multiple wavelengths between 600 nm and
850 nm at a single time point (15 weeks). Fig. 2c–f show a subset of
these images acquired at 600 nm and 850 nm as coronal x–y depth
color-coded maximum intensity projections (MIP). The sutures acted as
fiducial markers (Fig. 2b, blue arrows) enabling the scaffold to be un-
ambiguously located in the PA images. A dense web of vasculature, due
to neo-angiogenesis, is visible in the superficial region around the
scaffold as indicated by the yellow dotted ellipses in Fig. 2c and d. The
higher absorption of hemoglobin at 600 nm resulted in higher signal for
the superficial microvasculature compared to the 850 nm image (Fig. 2c
vs Fig. 2d); the signal was approximately an order of magnitude higher
at the shorter wavelength, although this is not visually apparent in
Fig. 2c and d as the image colour scale is mapped to depth rather than
signal amplitude. However, as seen in the transverse (x–z) MIPs (Fig. 2e
and f), the higher absorption results in significantly reduced imaging
depth at 600nm: while the sutures indicated by the blue arrows can be
seen at both 600 nm and 850 nm (Fig. 2e and f), the deeper blood
vessels which are located beneath the scaffold (indicated by yellow and
green arrows in Fig. 2b) are visible only at 850 nm (Fig. 2f). At 850 nm,
Fig. 3. Longitudinal in vivo photo-
acoustic images showing neovascular-
ization of a decellularized human
tissue-engineered scaffold. Horizontal
(x–y) maximum intensity projections
(MIPs) of 3D dataset obtained in the
same animal at (a) 3 weeks, (b) 5
weeks, (c) 8 weeks, (d) 12 weeks and
(e) 15 weeks after implantation of the
scaffold. All images were acquired at an
excitation wavelength of 600 nm as this
wavelength provided the highest vas-
cular contrast. The cross shaped sutures
helped to localize the scaffold at all the
time points. At three weeks after im-
plantation, only the microvasculature of
the murine skin was visible around the
scaffold. Beginning at 5 weeks, in-
creased contrast around the scaffold
indicated a region of neovascularization
(shown encircled with yellow dashed
lines). This region of neovascularization
increased between week 5 and week 8
before plateauing at 12 and 15 weeks.
(f) Increase in mean PA intensity of
voxels within the scaffold due to neo-
vascularization. The signal intensity at
five weeks is 28% greater than at three
weeks where the contrast is due to
normal microvasculature in the murine
skin. The increase in signal intensity is
151% at week 8, 150% at week 12, and
135% at week 15.
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it was possible to visualize features to a depth of approximately 6.8 mm
and thus image the full thickness of the scaffold. The 3D nature of the
image and the connectivity between vessels that extend from the skin
vasculature to the underside of the scaffold is clearly visible in an
animated volume rendered representation of the dataset (Online Video
1).
3.3. Longitudinal monitoring of neovascularization
Longitudinal photoacoustic images were also acquired non-in-
vasively at 3-, 5-, 8-, 12- and 15-week time points following scaffold
implantation in order to monitor neo-vascularization. For each time
point, Fig. 3 shows horizontal MIPs acquired at 600 nm as this wave-
length provided the highest vascular contrast, enabling the evolution of
the neo-vasculature to be visualized most clearly. The images in Fig. 3
clearly show the location of the sutures allowing unambiguous identi-
fication of the scaffold location at all time points. The image at three
weeks showed only the microvasculature of the murine skin (Fig. 3a)
with negligible neovascularization around the scaffold evident. Beyond
this time point, however, a region of increased contrast progressively
developed and expanded around the decellularized scaffold (Fig. 3b–e;
indicated by the dashed ellipse), indicating neo-vascularization, before
plateauing at weeks 12 and 15. To provide a quantitative estimate of
neovascularisation within the scaffolds, the mean intensity of voxels
that are above the noise floor in the area underneath the suture markers
(Fig. 3a–e) was calculated (Fig. 3f). The noise floor was obtained by
estimating the standard deviation of voxels above the mouse skin,
where there is no contrast, and multiplying by a factor of three to obtain
the peak value. The mean intensity of voxels within the scaffold at week
5 is 28% greater than at week 3 (Fig. 4f). The calculated increase is
151% at week 8, 150% at week 12, and 135% at week 15. The increase
in mean voxel intensity corresponds to an increase in vascular contrast
due to angiogenesis within the scaffold, since the contrast at week 3 is
due to microvasculature of the murine skin alone. Whilst the images in
Fig. 3 showed the development of the superficial vasculature with high
contrast, neo-angiogenesis around the lower surface of the scaffold was
not apparent due to the limited light penetration at 600 nm. However,
neo-vascularization around the underside of the scaffold was observed
at 850 nm due to deeper tissue penetration at this wavelength. An il-
lustrative example of this is provided in Fig. 4 which shows horizontal
(x–y) and vertical (x–z) MIPs of the same region as Fig. 3e.
3.4. Histological analysis
After scaffold retrieval at 15 weeks, hematoxylin and eosin (H&E)
staining showed infiltration of the scaffold periphery with host cells
(Fig. 5a). Consistent with previous observations [30], the cartilaginous
portion of the scaffold did not show cellular infiltration, presumably as
a result of its dense and avascular architecture (Fig. 5a). Next, we ex-
amined the presence of endomucin expression to identify the presence
of endothelial cells and to confirm our PAI results showing vascular
invasion both around and within the decellularized scaffolds
(Figs. 5b–d). The vascular size distribution was broad with pre-
dominantly small vessels within the scaffold, consistent with neo-
vascularization of the graft occurring through the generation of mi-
crovasculature from existing murine vascular networks in the
surrounding tissue.
4. Discussion
While the combination of cells, scaffolds and growth factors re-
quired for regeneration in tissue-engineered grafts are well-studied, the
ability of the host to revascularize transplanted grafts is a critical and
poorly understood process. This is in part because neovascularization is
most commonly studied at fixed time points by sectioning explanted
grafts and undertaking histological analysis. Current imaging mod-
alities for serial longitudinal observation of vascularization in vivo are
limited in terms of their resolution, contrast and invasiveness [7–13]
and as such have seen poor uptake in pre-clinical tissue engineering
studies. The development and application of novel technologies that
can image vascularization in tissue-engineered scaffolds is therefore
required.
Photoacoustic imaging (PAI) has the potential to address the lim-
itations of other imaging techniques on account of its ability to provide
high contrast, label-free images of the microvasculature with high re-
solution and penetration depth in an entirely non-invasive manner
[15,16]. Previous studies have shown success in using PAI to evaluate
neovascularization of non-biological scaffolds in vivo [17,19,20] but the
utility of PAI for imaging biological scaffolds, which are candidates for
practical application in clinical studies, has not been investigated. The
advantages of biological scaffolds over synthetic scaffolds lie in their
innate mimicry of native tissue architecture and their biocompatibility.
Of current biological scaffolds, decellularization of cadaveric donor
tissue has emerged as a promising candidate for larger human tissue
replacement procedures [21]. The decellularization process preserves
the native ultrastructure, matrix composition and tissue architecture,
thus providing an instructive microenvironment for tissue-specific cell
attachment, growth and differentiation, which is difficult to replicate in
de novo engineered scaffolds.
We were able to visualize neovascularization around a biological
tissue-engineered scaffold in vivo, with high resolution over extended
time periods without the need to perform a terminal procedure or use
invasive contrast agents. The use of PAI, in tomography mode, allowed
visualization of features to a depth of 6.8 mm which exceeds the depth
Fig. 4. In vivo photoacoustic image of scaffold acquired at week 15 of long-
itudinal study using an excitation wavelength of 850 nm. This wavelength pe-
netrates tissue more deeply than 600 nm enabling visualization of the neo-
vasculature around the lower surface of the scaffold. (a) Horizontal (x–y) MIP
with neo-vasculature beneath the scaffold false coloured yellow. The sutures
indicating the location of the scaffold false are coloured blue. (b) Vertical (x–z)
MIP. Yellow arrows indicate the neovascularization beneath the scaffold.
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of the implanted scaffold. This depth penetration is not achievable with
OR-PAM, which has an imaging depth limitation of approximately
1mm [22]. The use of different excitation wavelengths was also in-
vestigated to explore the trade-off between contrast and penetration
depth. A wavelength of 600 nm was identified as optimal for the de-
tection of smaller superficial vessels due to neovascularization. A longer
excitation wavelength of 850 nm allowed greater depth penetration
through the full thickness of the scaffold (Fig. 2f and Online Video 1)
and thus visualization of neovascularization around the underside of
the scaffold (Fig. 4). However, these images and the histological ana-
lysis suggest that the interior of the scaffold was largely avascular, as is
typical of cartilaginous structures.
Our longitudinal study shows neovascularization of the decellular-
ized construct over the course of fifteen weeks in vivo. An increase in
contrast, due to neovascularization, was visible around the scaffolds
after 5 weeks. This region of neovascularization increased at 8 weeks,
before plateauing at 12 and 15 weeks. This is broadly consistent with
the timescale observed in previous studies for the emergence of neo-
vessels in tissue-engineered scaffolds implanted subcutaneously in ro-
dents [31,32]. The extended duration of the study also takes into ac-
count any regional vasodilatory inflammatory effects which may occur
and contribute to increased vascularisation during the initial stages
after implantation of the scaffold. The time course of acute in-
flammatory response is in the order of days [33,34], hence any mi-
crovasculature observed in the region of the scaffold over the course of
several weeks in this study is expected to be as a result of neo-angio-
genesis rather than the consequences of local inflammation.
Histological analyses, on completion of the PAI studies, were also
consistent with the location and nature of vascularization observed by
PAI, with small vessels seen within and around the implanted decel-
lularized scaffold. These findings are in line with previous work in non-
biological scaffold imaging that suggest high correlation between mi-
crovascular changes shown by PAI and histological analyses [17]. Our
preliminary study provides important proof-of-concept for PAI in
clinically relevant tissue engineering applications and a useful, ex-
perimentally-based reference timeline for future studies, especially
studies aiming to enhance the vascularization of bioengineered scaf-
folds by the addition of cells or pro-angiogenic factors.
In the current study, images of vascular anatomy only were acquired
but PAI also has the potential to provide functional images [35] in
which physiological parameters such as blood oxygen saturation
[36,37] and flow velocity [38,39] can be measured. Hence, the tech-
nique has the potential to be used not only to monitor integration and
neovascularization of tissue-engineered constructs, but also to provide
crucial functional in vivo data [17,35]. Previous studies have explored
the use of PAI in monitoring the vascularisation of skin grafts following
burns injuries [40–43]. We foresee a similar role for PAI in surgical
procedures in where grafts are pre-vascularized in a heterotopic site:
the scaffold could then be imaged in situ to inform decisions about the
timing of its transplantation [44]. The widespread adoption of the
technique may be accelerated by the miniaturization of handheld PAI
devices and probes and is favored by the lower costs and high en-
dogenous contrast of PAI compared to alternative techniques such as
MRI and PET.
5. Conclusion
Establishing a vascular supply to tissue-engineered organs is critical
to their in vivo viability. As such, the ability to monitor neovascular-
ization in biological scaffolds in vivo, over extended periods of time, is
an important step towards the standardization of protocols relating to
their clinical implantation [45]. To our knowledge, this is the first study
to achieve this using a decellularized human tissue scaffold. Our results
suggest that photoacoustic imaging is a promising, non-invasive and
non-destructive method for assessing angiogenesis in biological tissue-
engineered scaffolds in vivo. Besides informing decision making in re-
lation to implanted tissue-engineered grafts, this technique could gen-
erate new hypotheses relating to neo-angiogenesis in such implants, the
exploration of which could, in turn, permit the testing of novel strate-
gies to improve nutrient supply to bioengineered and other trans-
planted tissues and organs.
Fig. 5. Histological analysis of decellularized human tracheal scaffolds retrieved 15 weeks after subcutaneous implantation in mice. (a) Haematoxylin and eosin (H&
E) staining of scaffold (located within dotted line) with adjacent deep muscle tissue (indicatedm) and superficial skin (indicated s). The scaffold contains a region of
cartilaginous tissue (indicated *). Cellular infiltrates were seen around and within the non-cartilaginous region of the scaffold. (b) Endomucin immunohistochemical
staining of vessels. Some artefacts from the loss of the scaffold tissue during processing can be seen. Boxed section C and D are representative ventral and dorsal
regions for further magnification. (c, d) Magnified endomucin staining of the microvascular infiltration of the mucosal region of scaffold. Red arrows indicate blood
vessels stained with endomucin located within the scaffold.
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